Transgene completes randomisation in phase 2 trial of tg4050
13th April 2026 Uncategorised 0
Company expects two‑year dfs data by q1 2028

More: Transgene completes randomisation in phase 2 trial of tg4050
Source: News
Company expects two‑year dfs data by q1 2028

More: Transgene completes randomisation in phase 2 trial of tg4050
Source: News
© 1994 - 2026 B.M. Pharmaceuticals